XenTech Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 31


  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

XenTech General Information


Provider of patient-derived tumor xenograft models designed to foster therapeutic development in oncology. The company's models focus on the pre-clinical evaluation of oncology therapeutics by offering translational platforms, enabling doctors to avail of relevant tumor models, and addressing tomorrow's needs in preclinical oncology research.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 4, rue Pierre Fontaine
  • 91000 Evry
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XenTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Aug-2022 00000 Completed Generating Revenue
4. Grant 16-Mar-2009 00000 Completed Generating Revenue
3. Seed Round 31-Oct-2008 00000 00000 00.000 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2006 Completed Startup
1. Accelerator/Incubator Completed Startup
To view XenTech’s complete valuation and funding history, request access »

XenTech Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 000.000000 0000.00 0000.00 00 0000.00 000
To view XenTech’s complete cap table history, request access »

XenTech Patents

XenTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200319182-A1 Methods based on the detection of rad51 foci in tumor cells Active 21-Dec-2017 000000000000
CA-3086794-A1 Methods based on the detection of rad51 foci in tumor cells Pending 21-Dec-2017 000000000000
AU-2018387831-A1 Methods based on the detection of rad51 foci in tumor cells Pending 21-Dec-2017 000000000000
EP-3502700-A1 Methods based on the detection of rad51 foci in tumor cells Inactive 21-Dec-2017 000000000000 0
JP-2021508835-A Method based on detection of rad51 phoci in tumor cells Active 21-Dec-2017 G01N33/57449 0
To view XenTech’s complete patent history, request access »

XenTech Executive Team (12)

Name Title Board Seat
Thierry Jean Ph.D Chief Executive Officer & Board Member
Marie Caussou Chief Financial Officer, Director of Administration & Manager of Human Resources
Philippe Michon Head of Business Development & Commercial Director
Delphine Nicolle Ph.D Study Director
Marie Tavernier Study Director
You’re viewing 5 of 12 executive team members. Get the full list »

XenTech Board Members (1)

Name Representing Role Since
Thierry Jean Ph.D XenTech Chief Executive Officer & Board Member 000 0000
To view XenTech’s complete board members history, request access »

XenTech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

XenTech Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
OSEO Innovation Venture Capital Minority 000 0000 000000 0
IncubAlliance Accelerator/Incubator Minority 000 0000 000000 0
Institut Curie Incubation Program Accelerator/Incubator 000 0000 000000 0
To view XenTech’s complete investors history, request access »

XenTech FAQs

  • When was XenTech founded?

    XenTech was founded in 2006.

  • Who is the founder of XenTech?

    Pascal Leuraud Ph.D is the founder of XenTech.

  • Who is the CEO of XenTech?

    Thierry Jean Ph.D is the CEO of XenTech.

  • Where is XenTech headquartered?

    XenTech is headquartered in Evry, France.

  • What is the size of XenTech?

    XenTech has 31 total employees.

  • What industry is XenTech in?

    XenTech’s primary industry is Drug Discovery.

  • Is XenTech a private or public company?

    XenTech is a Private company.

  • What is XenTech’s current revenue?

    The current revenue for XenTech is 00000.

  • How much funding has XenTech raised over time?

    XenTech has raised $794K.

  • Who are XenTech’s investors?

    OSEO Innovation, IncubAlliance, and Institut Curie Incubation Program have invested in XenTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »